Trevena, Inc. (NASDAQ:TRVN – Get Free Report)’s share price crossed above its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of $0.30 and traded as high as $0.90. Trevena shares last traded at $0.02, with a volume of 1,077 shares.
Trevena Trading Up 25.0%
The business has a 50-day moving average price of $0.30 and a two-hundred day moving average price of $0.84. The firm has a market capitalization of $14,385.00, a price-to-earnings ratio of 0.00 and a beta of 0.45.
Trevena Company Profile
Trevena, Inc, a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV250, a G protein biased delta-opioid receptor agonist for the treatment of acute migraine; TRV734, a small molecule G protein biased ligand of the MOR for the treatment of moderate-to-severe acute and chronic pain; and TRV045, a novel S1P modulator for managing chronic pain.
Featured Stories
- Five stocks we like better than Trevena
- What is the Shanghai Stock Exchange Composite Index?
- Datavault AI: The New AI Contender Backed by Big Funding
- How to Choose Top Rated Stocks
- CoreWeave: Why the New King of AI Infrastructure Has Room to Run
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- Top 3 Dividend Achievers for October: High Yields, Growth Ahead
Receive News & Ratings for Trevena Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trevena and related companies with MarketBeat.com's FREE daily email newsletter.
